Please login to the form below

Not currently logged in
Email:
Password:

Chase adds former Allergan execs to leadership team

Scott Giacobello and Gary Charbonneau join

Chase Pharmaceuticals Scott GiacobelloCalifornian Chase Pharmaceuticals has made two appointments to its senior leadership team.

Scott Giacobello (pictured right) becomes chief financial officer at the clinical-stage biopharma company, bringing almost 25 years of experience in finance and accounting.

Most recently, Giacobello served as vice president of finance for global research and development at Allergan, and has held financial positions at Black & Decker and Ernst & Young.

Meanwhile, Gary Charbonneau (pictured below) has been appointed as senior vice president for regulatory affairs and operations.

Charbonneau joins Chase with over 25 years of experience in regulatory, quality and research and development operations.

He moves from Allergan, where he spent 14 years in a number of senior regulatory positions, including his most recent role as vice president of international regulatory affairs.

Chase Pharmaceuticals Gary CharbonneauCharbonneau also brings experience from Amgen, Baxter, Novo Nordisk and Roche

Douglas Ingram, chief executive officer at Chase, said: “I could not be more delighted to welcome Scott and Gary to Chase.

“With its robust intellectual property, pharmaceutical assets and elegant development strategy, Chase has the opportunity to profoundly reshape the approach to the symptomatic treatment of Alzheimer's disease.

“Scott and Gary have the proven track records, enthusiasm and commitment to operational excellence that will help Chase succeed in improving the lives of millions of patients suffering from this devastating disease.”

20th June 2016

From: Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

The truth is out there: Patients first
Patient centricity, patient focus, patients first – words that are on everyone’s lips these days. But what do they really mean? Where does the patient voice fit in? And what...
mHealth: The revolution will not be digital
Could mHealth, which has been growing exponentially in recent years, be the answer we have been looking for to address our population health challenge? Could mHealth save healthcare?...
Medical information in precision medicine
Global Medical Information Leader James Oughton reveals the top trends in medical information and precision medicine....

Infographics